NEW YORK (GenomeWeb) – Cancer diagnostics developer Metamark Genetics announced today that it has signed a coverage deal for its urological cancer diagnostics with Blue Cross and Blue Shield of Texas, effective June 1.

The agreement covers all of BCBS insured members in Texas and gives them access to Metamark's array of urology specialized diagnostics.

Specific terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.